Clinical Trial: A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Psoriasis
Study Type: INTERVENTIONAL
Official Title: A Phase 2, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of Efficacy and Safety of SAR441566 in Adults With Moderate to Severe Plaque Psoriasis
Brief Summary:
This is a Phase 2, international, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, 12-week study.It is designed to assess the therapeutic dose, efficacy, and safety of treatment with SAR441566 in male and female adults with moderate to severe plaque psoriasis.Study details include a screening period (4 weeks and not less than 11 days before Day 1), a treatment period (12 weeks ± 3 days) and a post-treatment period (safety follow-up) (4 weeks ± 3 days).The total number of study visits will…
Read more